Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16321526rdf:typepubmed:Citationlld:pubmed
pubmed-article:16321526lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:16321526lifeskim:mentionsumls-concept:C0003195lld:lifeskim
pubmed-article:16321526lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:16321526lifeskim:mentionsumls-concept:C0232108lld:lifeskim
pubmed-article:16321526lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:16321526pubmed:issue5lld:pubmed
pubmed-article:16321526pubmed:dateCreated2006-1-27lld:pubmed
pubmed-article:16321526pubmed:abstractTextThe antiarrhythmic activity of 4,6-di(het)aryl-5-nitro-3,4-dihydropyrimidin-(1H)-2-ones toward two types of experimental rat arrhythmia has been studied. With CaCl(2) induced arrhythmia model, several agents have demonstrated high antiarrhythmic activity and the lack of influence on arterial pressure of rats.lld:pubmed
pubmed-article:16321526pubmed:languageenglld:pubmed
pubmed-article:16321526pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16321526pubmed:citationSubsetIMlld:pubmed
pubmed-article:16321526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16321526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16321526pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16321526pubmed:statusMEDLINElld:pubmed
pubmed-article:16321526pubmed:monthMarlld:pubmed
pubmed-article:16321526pubmed:issn0960-894Xlld:pubmed
pubmed-article:16321526pubmed:authorpubmed-author:BryzgalovArka...lld:pubmed
pubmed-article:16321526pubmed:authorpubmed-author:DolgikhMargar...lld:pubmed
pubmed-article:16321526pubmed:authorpubmed-author:SorokinaIrina...lld:pubmed
pubmed-article:16321526pubmed:authorpubmed-author:TolstikovaTat...lld:pubmed
pubmed-article:16321526pubmed:authorpubmed-author:SedovaValenti...lld:pubmed
pubmed-article:16321526pubmed:authorpubmed-author:ShkurkoOleg...lld:pubmed
pubmed-article:16321526pubmed:issnTypePrintlld:pubmed
pubmed-article:16321526pubmed:day1lld:pubmed
pubmed-article:16321526pubmed:volume16lld:pubmed
pubmed-article:16321526pubmed:ownerNLMlld:pubmed
pubmed-article:16321526pubmed:authorsCompleteYlld:pubmed
pubmed-article:16321526pubmed:pagination1418-20lld:pubmed
pubmed-article:16321526pubmed:meshHeadingpubmed-meshheading:16321526...lld:pubmed
pubmed-article:16321526pubmed:meshHeadingpubmed-meshheading:16321526...lld:pubmed
pubmed-article:16321526pubmed:meshHeadingpubmed-meshheading:16321526...lld:pubmed
pubmed-article:16321526pubmed:meshHeadingpubmed-meshheading:16321526...lld:pubmed
pubmed-article:16321526pubmed:meshHeadingpubmed-meshheading:16321526...lld:pubmed
pubmed-article:16321526pubmed:meshHeadingpubmed-meshheading:16321526...lld:pubmed
pubmed-article:16321526pubmed:meshHeadingpubmed-meshheading:16321526...lld:pubmed
pubmed-article:16321526pubmed:meshHeadingpubmed-meshheading:16321526...lld:pubmed
pubmed-article:16321526pubmed:year2006lld:pubmed
pubmed-article:16321526pubmed:articleTitleAntiarrhythmic activity of 4,6-di(het)aryl-5-nitro-3,4-dihydropyrimidin-(1H)-2-ones and its effects on arterial pressure in rats.lld:pubmed
pubmed-article:16321526pubmed:affiliationN.N. Vorozhtsov Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russian Federation. arkadiy@nioch.nsc.rulld:pubmed
pubmed-article:16321526pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:16321526lld:chembl